Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 3/20 | 0.33 |
| ▸ | ITK | Q08881 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.31 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12640473 | 1.00 | ALDH1A1 (0.39) | ALDH1A1CYP2A6HRH3GRM2MAPKAPK2 | |
| SCHEMBL12640480 | 0.95 | ABCG2 (0.36) | ALDH1A1CYP2A6HRH3GRM2MAPKAPK2 | |
| SCHEMBL12640465 | 0.95 | ABCG2 (0.36) | ALDH1A1CYP2A6HRH3GRM2MAPKAPK2 | |
| SCHEMBL17117411 | 0.94 | ABCG2 (0.37) | ALDH1A1CYP2A6HRH3ITKKDM1A | |
| SCHEMBL12640426 | 0.94 | PGR (0.37) | HRH3PGRKIF11 | |
| SCHEMBL17066409 | 0.92 | HRH3 (0.33) | ALDH1A1CYP2A6HRH3GRM2MAPKAPK2 | |
| SCHEMBL12575800 | 0.92 | ALDH1A1 (0.33) | ALDH1A1CYP2A6HRH3GRM2MAPKAPK2 | |
| SCHEMBL12575859 | 0.92 | ALDH1A1 (0.33) | ALDH1A1CYP2A6HRH3GRM2MAPKAPK2 | |
| SCHEMBL12640516 | 0.91 | ALDH1A1 (0.33) | ALDH1A1CYP2A6HRH3GRM2PGR | |
| SCHEMBL12640525 | 0.91 | HRH3 (0.34) | ALDH1A1CYP2A6HRH3GRM2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9287507-B2 | Organic electroluminescent element, compounds and materials used for the organic electroluminescent element, and light-emitting, display and illuminating devices using the elements | UDC Ireland (IE) | 2016-03-15 | — | — | US | disclosed |
| US-9126892-B2 | Blue fluorescence compound and organic electroluminescence device using the same | LG DISPLAY CO., LTD. (KR) | 2015-09-08 | — | — | US | disclosed |
| US-20130214259-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUNDS AND MATERIALS USED FOR THE ORGANIC ELECTROLUMINESCENT ELEMENT, AND LIGHT-EMITTING, DISPLAY AND ILLUMINATING DEVICES USING THE ELEMENTS | UDC IRELAND LIMITED (IE) | 2013-08-22 | — | — | US | disclosed |
| US-20130214259-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUNDS AND MATERIALS USED FOR THE ORGANIC ELECTROLUMINESCENT ELEMENT, AND LIGHT-EMITTING, DISPLAY AND ILLUMINATING DEVICES USING THE ELEMENTS | UDC IRELAND LIMITED (IE) | 2013-08-22 | — | — | US | disclosed |
| US-20110156011-A1 | BLUE FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110156011-A1 | BLUE FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | KCNN2, ORAI2, ETV6 | ALDH1A1 561/4885CYP2A6 3526/4885HRH3 4011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.